Praj Industries Ltd Q2 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/2rklficizufel6fr4mz7cogu.pdf

Key Takeaways


Domestic Ethanol: The Q2 Disruption

Joshipura: "…start, stop, negotiation, clarification and restart almost eight to 10 weeks, 12 weeks quarter, you lose eight weeks on to the most significant section and as you are aware that over the previous period, a large section of the order booking on ethanol was coming through the Starchy route."

US & International Bioenergy

Joshipura: "Our position in the United States market is not, it's actually not in any market for that matter- of a low-cost solution provider, we are very clearly saying we are best in class technology and therefore bat for me."

CBG: Orders Building, Pace Uncertain


Margins: Raw Materials Did the Work

Raole: "According to me around 75% to 80% is on account of raw material, because our execution is doing fine that we have seen some upside because of the large volume execution which we are doing, but measure contribution according to me is on account of raw material prices."

GenX, Pilots & New Business Lines

Joshipura: "We expect to commission this in the last quarter of the financial year. And once that is set up and we demonstrate then we will be able to be in a position to speak about the business that emanates out of that."

Order Book & Export Mix Shift


Guidance & Commitments

CommitmentSpecificsTimeline
H2 executionH2 execution will be larger than H1H2 FY24
US IRA clarificationExpected from US government; more orders may flow once receivedBy end of Q3 FY24
GenX commercial productionStart of commercial production at Mangalore facilityQ4 FY24 (Feb–Mar)
GenX revenueRevenue from Praj GenX to beginQ4 FY24
SAF pilot commissioningPilot plant to be commissionedQ4 FY24
PLA bio-plastics pilot commissioningPilot plant to be commissionedQ4 FY24
IOCL JV finalisationJV to be firmed up, enabling action on SAF and CBG projectsBy Q4 FY24
Export ratio targetShift from 20:80 to at least 30:70 export-to-domestic order ratioWithin two years
IOCL 2G plant performanceTwo-stage program to establish plant performanceNext six months

Key Metrics

MetricQ2 FY24
Consolidated income from operations₹882 cr
PBT₹84.81 cr, up 29% YoY from ₹65.78 cr
PAT₹62.37 cr, up from ₹48.13 cr in Q2 FY23
H1 FY24 income from operations₹1,619 cr
H1 FY24 PBT₹162 cr, up from ₹120 cr in H1 FY23
H1 FY24 PAT₹121 cr, up from ₹89.39 cr in H1 FY23
H1 margin expansion~2.2%
Export revenue share16% of Q2 FY24 revenue
Revenue mix79% Bio-energy, 15% engineering, 6% PHS
Order intake₹1,063 cr, 71% domestic
Order intake mix68% Bio-Energy, 22% engineering, 10% PHS
Order backlog₹3,960 cr as of Sept 2023, 74% domestic
International order book share29% of total order book in Q2; H1 share 32% vs 13% in H1 FY22
ETCA share in CPES order book52%
PHS order bookingCrossed ₹100 cr for the quarter
Cash in hand₹687 cr as of Sept 30, 2023
CAPEX guidance for FY24₹120 cr: ₹60 cr GenX, ₹20 cr routine, ₹40 cr pilot plants (SAF and PLA)
Services segment revenue₹10–15 cr out of total ₹880 cr
Current export-to-domestic order ratio20:80; target at least 30% international